Gestational diabetes, maternal obesity, and the NCD burden

Clinical Obstetrics and Gynecology

Volumn 56, Issue 3, 2013, Pages 633-641

  Ma, Ronald C W ^a   Chan, Juliana C N ^a   Tam, Wing Hung ^a   Hanson, Mark A ^b   Gluckman, Peter D ^c,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d AGENCY FOR SCIENCE   (Singapore)

Author keywords

epigenetics; evolution; gestational diabetes; intergenerational effects; maternal obesity; mismatch

Indexed keywords

GLUCOSE;

ENVIRONMENTAL FACTOR; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL OBESITY; MATERNAL WELFARE; NON COMMUNICABLE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PREGNANCY DIABETES MELLITUS; PRENATAL DIAGNOSIS; PREVALENCE; PROGENY; REVIEW;

BIOLOGICAL EVOLUTION; BIRTH WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84882453499     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31829e5bb0     Document Type: Review

References (55)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 countryyears and 2.7 million participants. Lancet. 2011; 378:31-40.
2. International Diabetes Federation. Diabetes Atlas. Fifth ed. Brussels, Belgium: The International Diabetes Federation.
3. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:408-418.
4. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-2140.
5. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol. 2012;8:228-236.
6. Gluckman PD, Hanson MA, Bateson P, et al. Towards a new developmental synthesis: adaptive developmental plasticity and human disease. Lancet. 2009;373:1654-1657.
7. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab. 2010;21:199-205.
8. Chiu M, Austin PC, Manuel DG, et al. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011;34:1741-1748.
9. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363:2339-2350.
10. Ma RC, Chan JC. Type 2 diabetes in East Asians-similarities and differences with European and US populations. Ann N Y Acad Sci. 2013;1281:64-91.
11. Gluckman PD, Hanson MA, Buklijas T. A conceptual framework for the developmental origins of health and disease. J Dev Origin Health Disease. 2010;1:6-18.
12. Kuzawa CW. Fetal origins of developmental plasticity: are fetal cues reliable predictors of future nutritional environments Am J Hum Biol. 2005;17:5-21.
13. Bateson P, Gluckman P. Plasticity, Robustness, Development and Evolution. 1st ed. New York: Cambridge University Press.
14. Gluckman P, Beedle AS, Hanson M. Principles of Evolutionary Medicine. Oxford, UK: Oxford University Press.
15. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science. 2004;305:1733-1736.
16. Gluckman PD, Hanson MA, Cooper C, et al. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359: 61-73.
17. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res. 2004;56:311-317.
18. Norman JF, LeVeen RF. Maternal atherogenic diet in swine is protective against early atherosclerosis development in offspring consuming an atherogenic diet post-natally. Atherosclerosis. 2001;157:41-47.
19. Bener A, Saleh NM, Al-Hamaq A. Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: global comparisons. Int J Womens Health. 2011;3:367-373.
20. Pettitt DJ, Aleck KA, Baird HR, et al. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes. 1988;37:622-628.
21. Sobngwi E, Boudou P, Mauvais-Jarvis F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet. 2003; 361:1861-1865.
22. Karter AJ, Rowell SE, Ackerson LM, et al. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 1999;22: 938-943.
23. Lee SC, Pu YB, Chow CC, et al. Diabetes in Hong Kong Chinese: evidence for familial clustering, maternal influence and a gender specific paternal effect. Diabetes Care. 2000;23:1365-1368.
24. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49:2208-2211.
25. Pettitt DJ, Lawrence JM, Beyer J, et al. Association between maternal diabetes in utero and age at offspring's diagnosis of type 2 diabetes. Diabetes Care. 2008;31:2126-2130.
26. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58:453-459.
27. Tam WH, Ma RC, Yang X, et al. Glucose intolerance and cardiometabolic risk in adolescents exposed to maternal gestational diabetes: a 15-year follow-up study. Diabetes Care. 2010;33: 1382-1384.
28. Ma RC, Chan JC. Pregnancy and diabetes scenario around the world: China. Int J Gynaecol Obstet. 2009;104 (suppl 1):S42-S45.
29. Yajnik CS. Fetal programming of diabetes: still so much to learn! Diabetes Care. 2010;33: 1146-1148.
30. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378: 169-181.
31. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. Jama. 2008;300:2886-2897.
32. Illsley NP. Glucose transporters in the human placenta. Placenta. 2000;21:14-22.
33. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011;18:409-416.
34. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980;29:1023-1035.
35. Susa JB, Schwartz R. Effects of hyperinsulinemia in the primate fetus. Diabetes. 1985;34 (suppl 2): 36-41.
36. Egeland GM, Skjaerven R, Irgens LM. Birth characteristics of women who develop gestational diabetes: population based study. Bmj. 2000;321: 546-547.
37. Hadden DR. Prediabetes and the big baby. Diabet Med. 2008;25:1-10.
38. Hanson MA, Gluckman PD, Ma RC, et al. Early life opportunities for prevention of diabetes in low and middle income countries. BMC Public Health. 2012;12:1025.
39. Osgood ND, Dyck RF, Grassmann WK. The inter-and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes. Am J Public Health. 2011;101:173-179.
40. Chamberlain C, McNamara B, Williams ED, et al. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States: a systematic review of the evidence for screening in early pregnancy. Diabetes Metab Res Rev. 2013;29:241-256.
41. Gluckman PD, Hanson MA, Beedle AS. Nongenomic transgenerational inheritance of disease risk. Bioessays. 2007;29:145-154.
42. Plagemann A, Harder T, Dudenhausen JW. The diabetic pregnancy, macrosomia, and perinatal nutritional programming. Nestle Nutr Workshop Ser Pediatr Program. 2008;61:91-102.
43. Bouchard L, Thibault S, Guay SP, et al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care. 2010;33:2436-2441.
44. Bouchard L, Hivert MF, Guay SP, et al. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes. 2012;61:1272-1280.
45. Ding GL,Wang FF, Shu J, et al. Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes. 2012;61:1133-1142.
46. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
47. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676-682.
48. Sacks DA, Hadden DR, Maresh M, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012;35:526-528.
49. Jenum AK, Morkrid K, Sletner L, et al. Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol. 2012;166:317-324.
50. Parlea L, Bromberg IL, Feig DS, et al. Association between serum 25-hydroxyvitamin Din early pregnancy and risk of gestational diabetes mellitus. Diabet Med. 2012;29:e25-e32.
51. Catalano PM,EhrenbergHM.The short-and longterm implications of maternal obesity on the mother and her offspring. BJOG. 2006;113:1126-1133.
52. Reynolds RM, Osmond C, Phillips DI, et al. Maternal BMI, parity, and pregnancy weight gain: influences on offspring adiposity in young adulthood. J Clin Endocrinol Metab. 2010;95: 5365-5369.
53. Johnsen SL, Wilsgaard T, Rasmussen S, et al. Fetal size in the second trimester is associated with the duration of pregnancy, small fetuses having longer pregnancies. BMC Pregnancy Childbirth. 2008;8:25.
54. Godfrey KM, Sheppard A, Gluckman PD, et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes. 2011;60:1528-1534.
55. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30 (suppl 2):S141-S146.